샘플 요청 목록

 카트 문의
시장보고서
상품코드
1766989

세계의 피듀셜 마커 시장

Fiducial Markers
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 378 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

피듀셜 마커 세계 시장은 2030년까지 1억 6,640만 달러에 달할 전망

2024년에 1억 2,380만 달러로 추정되는 피듀셜 마커 세계 시장은 2024년부터 2030년까지 CAGR 5.1%로 성장하여 2030년에는 1억 6,640만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 금속은 CAGR 5.8%를 기록하며 분석 기간 종료시에는 7,620만 달러에 달할 것으로 예측됩니다. 폴리머 부문의 성장률은 분석 기간 동안 CAGR 4.6%로 추정됩니다.

미국 시장은 3,230만 달러로 추정, 중국은 CAGR 8.0%로 성장 예측

미국의 피듀셜 마커 시장은 2024년에는 3,230만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 8.0%로 성장하여 2030년에는 예측 시장 규모 3,780만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 2.8%와 4.1%로 예측됩니다. 유럽에서는 독일이 CAGR 약 3.5%로 성장할 것으로 예측됩니다.

세계 피듀셜 마커 시장 - 주요 동향 및 촉진요인 정리

의료 영상 진단 및 방사선 치료에서 피듀셜 마커에 대한 수요를 주도하는 요인은 무엇인가?

피듀셜 마커는 영상 진단 및 방사선 치료의 정확성을 높이기 위해 의료 분야, 특히 종양학 분야에서 수요가 증가하고 있습니다. 피듀셜 마커는 종양 내 또는 종양 근처에 설치되는 작은 금속 또는 폴리머 마커로, 체내 종양의 정확한 위치를 파악하는 데 도움을 주며, 정위적 방사선 치료(SBRT), 강도변조 방사선 치료(IMRT) 등의 치료에서 의사가 타겟팅 정확도를 향상시킬 수 있도록 도와줍니다. 이러한 정확도는 주변 건강한 조직에 대한 손상을 줄여 부작용을 줄이고 환자의 예후를 개선할 수 있습니다. 전 세계적으로 암 환자가 증가하는 가운데, 피듀셜 마커는 전립선암, 폐암, 간암 등 다양한 종류의 암에 정확한 방사선량을 조사하기 위해 높은 수요가 있습니다.

피듀셜 마커는 방사선 치료 외에도 CT, MRI, 초음파 등의 영상 진단 기술에도 사용되며, 최소침습 수술이나 생검 시 종양 및 기타 구조물을 시각화하는 데 도움을 주고 있습니다. 환자 개개인의 필요에 따라 치료를 맞춤화하는 정밀의료에 대한 관심이 높아지는 것은 피듀셜 마커 시장의 주요 촉진요인이며, 특히 북미와 유럽과 같이 의료 인프라가 발달한 지역에서는 정확성과 최소침습적 기술이 우선시되고 있습니다.

기술 발전이 피듀셜 마커 개발에 어떤 영향을 미치고 있는가?

재료 과학과 마커 디자인의 기술적 진보로 인해 피듀셜 마커의 안전성, 가시성 및 생체적합성이 향상되고 있습니다. 금, 백금, 생분해성 폴리머의 사용을 포함한 마커 재료의 혁신은 피듀셜 마커의 체내 안정성과 적합성을 향상시킵니다. 예를 들어, 금 마커는 이미지 스캔에서 높은 가시성을 제공하는 동시에 비반응성이며 환자에게 안전하기 때문에 장기적인 체내 삽입에 적합합니다. 또한 서서히 용해되는 생분해성 마커는 외과적 제거의 필요성을 줄여 환자의 편안함과 편의성을 향상시킵니다.

헬리컬 마커 및 멀티 부문 마커와 같은 첨단 디자인은 연조직 내 고정성을 향상시키고, 이동을 방지하며, 정확한 타겟팅을 위한 안정적인 배치를 보장합니다. 마커는 또한 MRI 유도하 치료를 받는 환자를 위한 MRI 적합성 마커와 같이 특정 영상 양식에 적합하도록 설계되어 있습니다. 이러한 기술적 발전으로 인해 피듀셜 마커의 적용 범위가 확대되어 환자의 안전과 편안함을 향상시키면서 치료 및 영상 진단의 정확성을 향상시키고 있습니다.

정밀의료와 최소침습의 트렌드가 피듀셜 마커 시장 형성에 어떤 역할을 하고 있는가?

정밀의료와 최소침습 치료로의 전환은 피듀셜 마커에 대한 수요를 촉진하고 있습니다. 이러한 접근 방식은 정확성과 개인화된 치료에 중점을 두고 있기 때문입니다. 피듀셜 마커는 종양의 위치를 파악하고 실시간 영상 가이던스를 지원하는 중요한 역할을 합니다. 이는 표적 치료를 제공하고 최소침습적 치료로 좋은 결과를 얻기 위해 필수적입니다. 예를 들어, 전립선암 치료에서 피듀셜 마커는 정확한 방사선 조사가 가능하여 인접 장기의 손상 위험을 줄일 수 있습니다.

최소침습 수술은 접근 포인트가 제한되어 있기 때문에 정확한 시각화에 크게 의존하고 있습니다. 피듀셜 마커를 사용함으로써 외과의사와 방사선사는 이러한 시술 중 높은 정확도를 유지하여 성공률을 높이고 회복 시간을 단축할 수 있습니다. 의료 시스템이 정확성을 우선시하고 부작용을 최소화하는 환자 중심 진료에 초점을 맞추고 있는 가운데, 피듀셜 마커는 치료와 진단 모두에서 필수적인 도구가 되고 있습니다.

피듀셜 마커 시장의 성장을 촉진하는 요인은 무엇인가?

피듀셜 마커 시장의 성장은 암 발병률 증가, 정밀 영상 및 방사선 치료의 발전, 최소침습적 기술의 채택, 맞춤형 치료에 대한 수요에 기인합니다. 전립선암, 폐암, 간암 등의 발병률이 증가함에 따라 피듀셜 마커는 치료의 정확도를 높이고 주변 조직 손상을 최소화하는 데 중요한 역할을 하고 있으며, MRI 적합성 및 생분해성 옵션과 같은 마커의 소재 및 디자인 혁신은 다양한 치료법에 대한 적용을 확대하여 치료의 효과와 효율을 높일 수 있습니다. 다양한 치료법에 적용을 확대하여 효과와 환자 경험을 모두 향상시키고 있습니다.

정밀의료와 최소침습적 치료의 발전은 실시간 이미징과 이러한 접근법에서 표적 치료를 가능하게 하는 피듀셜 마커가 성장의 원동력이 되고 있습니다. 첨단 암 치료에 대한 전 세계적인 인식과 투자가 증가함에 따라 피듀셜 마커는 개인화되고 정확성에 초점을 맞춘 헬스케어 전략에 필수적인 요소로 자리 잡고 있습니다. 암 발병률 증가, 기술 발전, 정밀의료, 최소침습적 치료의 추세 등 다양한 요인들이 결합하여 피듀셜 마커 시장의 강력한 성장을 촉진하고, 현대 의학에서 치료의 정확성과 환자 예후를 개선하는 데 중요한 역할을 하고 있습니다.

부문

제품 유형(금속, 폴리머, 기타 제품 유형), 모달리티(CT/CBCT, MRI, 초음파, 방사선 치료), 최종사용자(병원 및 외래 환자 시설, 독립 방사선 치료 센터, 암 연구 센터)

조사 대상 기업 사례

  • Beekley Corporation
  • Best Medical International, Inc.
  • Boston Scientific Corporation
  • Carbon Medical Technologies
  • CIVCO Radiotherapy
  • Eckert & Ziegler
  • IBA
  • Innomedicus AG
  • Innovative Oncology Solutions
  • IZI Medical Products
  • JJ-Medtech
  • Meditronix Corporation
  • Medtronic
  • Nanovi A/S
  • Naslund Medical AB
  • QFIX
  • QlRad Inc.
  • Seedos Ltd
  • Stellar Medical
  • Varian Medical Systems, Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴로 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범에 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.16

Global Fiducial Markers Market to Reach US$166.4 Million by 2030

The global market for Fiducial Markers estimated at US$123.8 Million in the year 2024, is expected to reach US$166.4 Million by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Metal, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$76.2 Million by the end of the analysis period. Growth in the Polymer segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$32.3 Million While China is Forecast to Grow at 8.0% CAGR

The Fiducial Markers market in the U.S. is estimated at US$32.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$37.8 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Fiducial Markers Market - Key Trends & Drivers Summarized

What Is Driving Demand for Fiducial Markers in Medical Imaging and Radiation Therapy?

The demand for fiducial markers is increasing in the medical field, particularly in oncology, as they enhance precision in imaging and radiation therapy. Fiducial markers, often small metal or polymer markers placed in or near tumors, help define the exact location of a tumor within the body, enabling doctors to improve targeting accuracy in treatments like stereotactic body radiotherapy (SBRT) and intensity-modulated radiation therapy (IMRT). This precision reduces damage to surrounding healthy tissues, resulting in fewer side effects and improved patient outcomes. As cancer cases rise globally, fiducial markers are in high demand for accurately delivering radiation doses to various cancer types, such as prostate, lung, and liver cancers.

In addition to radiotherapy, fiducial markers are also used in diagnostic imaging techniques like CT, MRI, and ultrasound to help visualize tumors and other structures during minimally invasive surgeries and biopsy procedures. The growing focus on precision medicine, which tailors treatment to individual patient needs, is a major driver of the fiducial markers market, particularly in regions with advanced healthcare infrastructure, such as North America and Europe, where accuracy and minimally invasive techniques are prioritized.

How Are Technological Advancements Impacting the Development of Fiducial Markers?

Technological advancements in materials science and marker design are enhancing the safety, visibility, and biocompatibility of fiducial markers. Innovations in marker materials, including the use of gold, platinum, and biodegradable polymers, improve the stability and compatibility of fiducial markers within the body. Gold markers, for instance, offer high visibility on imaging scans while remaining non-reactive and safe for patients, making them suitable for long-term placement. Additionally, biodegradable markers that gradually dissolve reduce the need for surgical removal, enhancing patient comfort and convenience.

Advanced designs, such as helical and multi-segment markers, improve fixation within soft tissues, preventing migration and ensuring stable placement for accurate targeting. Markers are also being designed for compatibility with specific imaging modalities, such as MRI-compatible markers for patients undergoing MRI-guided treatments. These technological advancements are expanding the application of fiducial markers, improving the accuracy of treatment and imaging while enhancing patient safety and comfort.

What Role Do Precision Medicine and Minimally Invasive Trends Play in Shaping the Fiducial Markers Market?

The shift toward precision medicine and minimally invasive procedures is driving demand for fiducial markers, as these approaches emphasize accuracy and personalized treatment. Fiducial markers play a crucial role in localizing tumors and supporting real-time imaging guidance, which is essential for delivering targeted therapies and achieving favorable outcomes in minimally invasive procedures. For instance, in prostate cancer treatments, fiducial markers allow for precise radiation targeting, reducing the risk of damaging adjacent organs.

Minimally invasive procedures rely heavily on accurate visualization, as they involve limited access points. Fiducial markers enable surgeons and radiologists to maintain high levels of precision during these procedures, improving success rates and reducing recovery times. As healthcare systems focus on patient-centric care that prioritizes accuracy and minimizes side effects, fiducial markers are becoming indispensable tools in both therapeutic and diagnostic settings.

What Factors Are Driving Growth in the Fiducial Markers Market?

The growth in the fiducial markers market is driven by the rise in cancer prevalence, advancements in precision imaging and radiotherapy, the adoption of minimally invasive techniques, and the demand for personalized treatment. As the incidence of cancers such as prostate, lung, and liver cancers increases, fiducial markers play a critical role in improving the accuracy of treatment and minimizing damage to surrounding tissues. Innovations in marker materials and designs, including MRI-compatible and biodegradable options, have expanded their application in various treatment modalities, enhancing both effectiveness and patient experience.

The move toward precision medicine and minimally invasive procedures is also driving growth, as fiducial markers enable real-time imaging and targeted treatment in these approaches. With increasing awareness and investment in advanced cancer treatments globally, fiducial markers are becoming essential components of personalized and precision-focused healthcare strategies. Together, these factors-rising cancer rates, technological advancements, precision medicine, and minimally invasive trends-are propelling robust growth in the fiducial markers market, supporting its role in improving treatment accuracy and patient outcomes in modern medicine.

SCOPE OF STUDY:

The report analyzes the Fiducial Markers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Metal, Polymer, Other Product Types); Modality (CT / CBCT, MRI, Ultrasound, Radiotherapy); End-Use (Hospitals & Outpatient Facilities, Independent Radiotherapy Centers, Cancer Research Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Beekley Corporation
  • Best Medical International, Inc.
  • Boston Scientific Corporation
  • Carbon Medical Technologies
  • CIVCO Radiotherapy
  • Eckert & Ziegler
  • IBA
  • Innomedicus AG
  • Innovative Oncology Solutions
  • IZI Medical Products
  • JJ-Medtech
  • Meditronix Corporation
  • Medtronic
  • Nanovi A/S
  • Naslund Medical AB
  • QFIX
  • QlRad Inc.
  • Seedos Ltd
  • Stellar Medical
  • Varian Medical Systems, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Fiducial Markers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer and Need for Accurate Tumor Localization Drives Demand for Fiducial Markers in Radiation Therapy
    • Growing Focus on Precision Medicine Propels Use of Fiducial Markers in Personalized Cancer Treatment Protocols
    • Technological Advancements in Imaging Techniques, Including MRI and CT Compatibility, Strengthen the Business Case for Fiducial Markers
    • Increasing Adoption of Fiducial Markers in Minimally Invasive Procedures Expands Market for Marker-Assisted Surgeries
    • Expanding Role of Fiducial Markers in Biopsy and Tumor Mapping Applications Drives Demand in Diagnostic Oncology
    • Rising Use of Image-Guided Radiotherapy (IGRT) and Stereotactic Body Radiotherapy (SBRT) Propels Market for High-Precision Fiducial Markers
    • Development of Biodegradable and Bio-Inert Fiducial Markers Enhances Safety and Expands Clinical Applications
    • Growing Demand for Real-Time Tracking in Complex Radiotherapy Treatments Spurs Innovations in Marker Design and Materials
    • Increased Focus on Patient Comfort and Reduced Complications Drives Development of Smaller, More Versatile Fiducial Markers
    • Advancements in Robotic-Assisted Surgeries Highlight Fiducial Markers as Essential for Accurate Surgical Navigation
    • Expanding Applications of Fiducial Markers in Neurology and Brain Mapping Increases Market Potential in Neurosurgery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Fiducial Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Metal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cancer Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cancer Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cancer Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals & Outpatient Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals & Outpatient Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospitals & Outpatient Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Independent Radiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Independent Radiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Independent Radiotherapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for CT / CBCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for CT / CBCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for CT / CBCT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Radiotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Radiotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Radiotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Fiducial Markers Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • JAPAN
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • CHINA
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • EUROPE
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Fiducial Markers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • FRANCE
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • GERMANY
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Fiducial Markers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • INDIA
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Fiducial Markers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Fiducial Markers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • AFRICA
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제